Clinical Trial: Bepirovirsen Liver Biopsy Study

U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07696520) titled 'Bepirovirsen Liver Biopsy Study' on July 06.

Brief Summary: Bepirovirsen Liver Biopsy study is a single centre open label phase II study to examine the antiviral and immunological effects of bepirovirsen in CHB patients both treated and untreated with HBsAg<1000 IU/ml

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: HEPATITIS B CHRONIC Hepatitis B Chronic Infection

Intervention: DRUG: Bepirovirsen

Weekly Bepirovirsen treatment for 24 weeks, with loading doses

PROCEDURE: Liver biopsy

Liver biopsy as previously described

PROCEDURE: Optional Liver biopsy

An optional Liver biopsy as previously described

Recrui...